Today's Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical
Briefly

Today's Market Moving Stocks: Affirm Holdings, Expedia, and Globus Medical
"Shares of Affirm Holdings ( NASDAQ: AFRM) are up about 9%, or by $5.88 on the day. All thanks to solid earnings. EPS of 23 cents beat estimates by 12 cents. Revenue of $933.34 million, up 33.6% year over year, beat by $49.98 million. It also gained on gross merchandise volume (GMV) guidance, now expecting to see it at $47.5 billion as compared to earlier estimates of $46 billion. Adjusted operating margin is now anticipated to be 27.1%, as compared to an earlier estimate of 26.1%."
"Expedia Group (NASDAQ: EXPE): Up about 17%, or by $37.47 a share, Expedia is running on strong earnings. The company also raised its 2025 revenue growth forecast. In fact, it now expects to see revenue growth of between 6% and 7%, as compared to earlier estimates of 3% to 5%. Bookings in its B2B segment jumped 26% to $9.38 billion during the third quarter."
"Globus Medical (NYSE: GMED): Up about 29%, or by $18 a share, GMED is also running on earnings. Its EPS OF $1.18 beat by 41 cents. Revenue of $769 million, up about 23%, beat by $34.33 million. Plus, analysts at Piper Sandler just raised its price target on GMED to $90 on profitability gains, with an overweight rating. "Profitability emerged as the standout metric for the quarter, with management attributing the improvement to acceleration in U.S. spine sales and manufacturing initiatives, factors that Piper Sandler expects to continue benefiting the company moving forward," added Investing.com."
Affirm Holdings shares rose about 9% after EPS of $0.23 beat estimates by $0.12 and revenue of $933.34 million, up 33.6% year over year, beat by $49.98 million. Affirm raised GMV guidance to $47.5 billion and now anticipates an adjusted operating margin of 27.1%. Expedia shares climbed roughly 17% after raising its 2025 revenue growth forecast to 6–7% and reporting a 26% jump in B2B bookings to $9.38 billion. Globus Medical surged about 29% after EPS of $1.18 and revenue of $769 million beat estimates, and Piper Sandler raised its price target to $90. Akamai rose about 10% with an EPS beat and revenue of $1.05 billion and offered guidance for adjusted earnings and sales ranges.
Read at 24/7 Wall St.
Unable to calculate read time
[
|
]